- Published at
- by prnewswire.com
mixed
mixed
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023
/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...